This article outlines the latest legislation for some of the most common post-authorisation documents (Risk Management Plans, Periodic Safety Update Reports, and Post-authorisation Safety Studies) and explains the role of the strategic medical writer. The strengthening of post-authorisation legislation has led to documents with new and improved formats. At the same time, the strategic medical writer's role has evolved almost in parallel with these legislative changes. The strategic medical writer contributes document and scientific expertise, writing skills, and project leadership through effective communication, and also provides an invaluable link in the team in the development of post-authorisation documents by anticipating problems, managing the review process, advising on data presentation, and ensuring compliance with guidelines. This process results in the production of high-quality documents, makes the submission process smoother, promotes the strengthening of the pharmacovigilance system, and ultimately contributes to patient safety.
Editor-in-Chief
Co-Editors
Managing Editor
Victoria White
Deputy Managing Editor
Alicia Waltman
Associate Editors
Section Editors
Biotechnology
Digital Communication
EMWA News
Getting Your Foot in the Door
Good Writing Practice
Alison McIntosh / Stephen Gilliver
In the Bookstores
Manuscript Writing
Medical Communications/Writing for Patients
Medical Devices
My First Medical Writing
News from the EMA
Out on Our Own
Pharmacovigilance
Regulatory Matters
Regulatory Public Disclosure
Teaching Medical Writing
The Crofter: Sustainable Communications
Veterinary Writing
Editors Emeritus
Lay out Designer
Chris Monk